Clinical Trial Update: Targeted Decision Making In Renal Cell Carcinoma Relying on a Radiogenomics Translational Platform

View source ↗

Summary

A clinical trial investigating radiogenomics-based decision making for renal cell carcinoma, currently recruiting under IRCCS San Raffaele.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Renal Tumors | Status: RECRUITING